Library Subscription: Guest
Critical Reviews™ in Neurobiology

Published 3 issues per year

ISSN Print: 0892-0915

ISSN Online: 2375-0014

SJR: 0.121

A Noradrenergic and Serotonergic Hypothesis of the Linkage Between Epilepsy and Affective Disorders

Volume 13, Issue 4, 1999, pp. 317-356
DOI: 10.1615/CritRevNeurobiol.v13.i4.10
Get accessGet access

ABSTRACT

Noradrenergic and/or serotonergic deficits, as well as other abnormalities, may contribute to predisposition to some epilepsies and depressions. Evidence for this hypothesis stems from several sources. Epidemiological investigations are intriguing but incomplete. Pharmacological studies show that noradrenergic and/or serotonergic transmission are both anticonvulsant and antidepressant. Therapeutically pertinent investigations show that antidepressant drugs have anticonvulsant properties, whereas antiepileptic drugs are effective in the management of affective disorders. Additional investigations demonstrate that seizures, whether spontaneously occurring or therapeutically induced, protect against depression. Through studies of innate pathophysiology, noradrenergic and serotonergic deficits have been identified in individuals with depression and in animal models of epilepsy, as well as in some humans with epilepsy. Vagal nerve stimulation, a treatment already known to be effective in the epilepsies, is presently under investigation for effectiveness in affective disorder. New evidence suggests that vagal nerve stimulation exerts at least some of its therapeutic effects through its capacity to increase noradrenergic and serotonergic transmission. Finally, emerging evidence supports the concept that some genetic mammalian models of the human epilepsies exhibit analogous manifestations of depression.

CITED BY
  1. Mao Ke, Lei Ding, Zhang Heng, You Chao, Anticonvulsant effect of piperine ameliorates memory impairment, inflammation and oxidative stress in a rat model of pilocarpine-induced epilepsy, Experimental and Therapeutic Medicine, 13, 2, 2017. Crossref

  2. Salpekar Jay A., Mishra Gaurav, J. Hauptman Aaron, Key issues in addressing the comorbidity of depression and pediatric epilepsy, Epilepsy & Behavior, 46, 2015. Crossref

  3. Al-Shorbagy Muhammad Y., El Sayeh Bahia M., Abdallah Dalaal M., Chang Alice Y. W., Additional Antiepileptic Mechanisms of Levetiracetam in Lithium-Pilocarpine Treated Rats, PLoS ONE, 8, 10, 2013. Crossref

  4. Clinckers Ralph, Smolders Ilse, Meurs Alfred, Ebinger Guy, Michotte Yvette, Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures, Neuropharmacology, 47, 7, 2004. Crossref

  5. De-Miguel Francisco F., Trueta Citlali, Synaptic and Extrasynaptic Secretion of Serotonin, Cellular and Molecular Neurobiology, 25, 2, 2005. Crossref

  6. Groves Duncan A., Brown Verity J., Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects, Neuroscience & Biobehavioral Reviews, 29, 3, 2005. Crossref

  7. Kanner Andres M., Depression in Epilepsy: A Neurobiologic Perspective, Epilepsy Currents, 5, 1, 2005. Crossref

  8. De Sarro Giovambattista, Russo Emilio, Citraro Rita, Meldrum Brian S., Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs, Epilepsy & Behavior, 71, 2017. Crossref

  9. Malhi Gin S, Sachdev Perminder, Novel physical treatments for the management of neuropsychiatric disorders, Journal of Psychosomatic Research, 53, 2, 2002. Crossref

  10. Cardamone L, Salzberg MR, O'Brien TJ, Jones NC, Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?, British Journal of Pharmacology, 168, 7, 2013. Crossref

  11. Kanner Andres M., Do epilepsy and psychiatric disorders share common pathogenic mechanisms? A look at depression and epilepsy, Clinical Neuroscience Research, 4, 1-2, 2004. Crossref

  12. Hamiwka L.D., Wirrell E.C., Comorbidities in Pediatric Epilepsy: Beyond ``Just'' Treating the Seizures, Journal of Child Neurology, 24, 6, 2009. Crossref

  13. Singh Tanveer, Goel Rajesh Kumar, Adjuvant indoleamine 2,3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression, European Journal of Pharmacology, 784, 2016. Crossref

  14. Alsaadi Taoufik, Neuropsychiatric issues in patients with epilepsy: focus on depression, Therapy, 7, 5, 2010. Crossref

  15. Mishra Awanish, Goel Rajesh Kumar, Psychoneurochemical Investigations to Reveal Neurobiology of Memory Deficit in Epilepsy, Neurochemical Research, 38, 12, 2013. Crossref

  16. Palomo Tomas, Kostrzewa Richard M., Beninger Richard J., Archer Trevor, Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders, Neurotoxicity Research, 12, 1, 2007. Crossref

  17. Choi Hui-Chul, Kim Yeong-In, Song Hong-Ki, Kim Ji-Eun, Kim Duk-Soo, Kang Tae-Cheon, Effects of selective serotonin reuptake inhibitors on GABAergic inhibition in the hippocampus of normal and pilocarpine induced epileptic rats, Brain Research, 1357, 2010. Crossref

  18. Husted David S., Shapira Nathan A., A Review of the Treatment for Refractory Obsessive-Compulsive Disorder: From Medicine to Deep Brain Stimulation, CNS Spectrums, 9, 11, 2004. Crossref

  19. Tchekalarova Jana, Petkova Zlatina, Pechlivanova Daniela, Moyanova Slavianka, Kortenska Lidia, Mitreva Rumiana, Lozanov Valentin, Atanasova Dimitrina, Lazarov Nikolai, Stoynev Alexander, Prophylactic treatment with melatonin after status epilepticus: Effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy, Epilepsy & Behavior, 27, 1, 2013. Crossref

  20. Jobe Phillip C., Browning Ronald A., The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant, Epilepsy & Behavior, 7, 4, 2005. Crossref

  21. Taiwe Germain Sotoing, Tchoya Thierry Bang, Menanga Joseph Renaud, Dabole Bernard, De Waard Michel, Anticonvulsant activity of an active fraction extracted from Crinum jagus L. (Amaryllidaceae), and its possible effects on fully kindled seizures, depression-like behaviour and oxidative stress in experimental rodent models, Journal of Ethnopharmacology, 194, 2016. Crossref

  22. Krämer Günter, Broadening the Perspective: Treating the Whole Patient, Epilepsia, 44, 2003. Crossref

  23. Ekblad E., Sundler F., Chapter 9 Innervation of the small intestine, in Biology of the Intestine in Growing Animals, 1, 2002. Crossref

  24. Berntsson Shala Ghaderi, Malmer Beatrice, Bondy Melissa L., Qu Mingqi, Smits Anja, Tumor-associated epilepsy and glioma: Are there common genetic pathways?, Acta Oncologica, 48, 7, 2009. Crossref

  25. Sajatovic Martha, Welter Elisabeth, Tatsuoka Curtis, Perzynski Adam T., Einstadter Douglas, Electronic medical record analysis of emergency room visits and hospitalizations in individuals with epilepsy and mental illness comorbidity, Epilepsy & Behavior, 50, 2015. Crossref

  26. Kanner Andres M., The Complex Epilepsy Patient: Intricacies of Assessment and Treatment, Epilepsia, 44, 2003. Crossref

  27. Szyndler Janusz, Maciejak Piotr, Turzyńska Danuta, Sobolewska Alicja, Bidziński Andrzej, Płaźnik Adam, Time course of changes in the concentrations of monoamines in the brain structures of pentylenetetrazole-kindled rats, Journal of Neural Transmission, 117, 6, 2010. Crossref

  28. Sun Xian-Yu, Zhang Lei, Wei Cheng-Xi, Piao Hu-Ri, Quan Zhe-Shan, Characterization of the anticonvulsant activity of doxepin in various experimental seizure models in mice, Pharmacological Reports, 61, 2, 2009. Crossref

  29. Popławska Monika, Wróblewska Dorota, Borowicz Kinga K., Interactions between an antidepressant reboxetine and four classic antiepileptic drugs in the mouse model of myoclonic seizures, Pharmacological Reports, 67, 6, 2015. Crossref

  30. Barry John J., The Recognition and Management of Mood Disorders as a Comorbidity of Epilepsy, Epilepsia, 44, 2003. Crossref

  31. Rzezak Patrícia, Fuentes Daniel, Guimarães Catarina A., Guerreiro Marilisa, Valente Kette D. R., A disfunção do lobo frontal em crianças e adolescentes com epilepsia de lobo temporal e sua possível correlação com a ocorrência de transtornos psiquiátricos, Journal of Epilepsy and Clinical Neurophysiology, 11, 3, 2005. Crossref

  32. Ziai Wendy C., Sherman David L., Bhardwaj Anish, Zhang Ning, Keyl Penelope M., Mirski Marek A., Target-specific Catecholamine Elevation Induced by Anticonvulsant Thalamic Deep Brain Stimulation, Epilepsia, 46, 6, 2005. Crossref

  33. Jobe Phillip C., Are there specific anatomical and/or transmitter systems (cortical or subcortical) that should be targeted?, in Epilepsy, Infantile Spasms, and Development Encephalopathy, 49, 2002. Crossref

  34. Grabowska-Grzyb Ałbena, Jędrzejczak Joanna, Nagańska Ewa, Fiszer Urszula, Risk factors for depression in patients with epilepsy, Epilepsy & Behavior, 8, 2, 2006. Crossref

  35. Smolders Ilse, Clinckers Ralph, Michotte Yvette, Microdialysis as a Tool to Unravel Neurobiological Mechanisms of Seizures and Antiepileptic Drug Action, in Applications of Microdialysis in Pharmaceutical Science, 2011. Crossref

  36. Epps S. Alisha, Weinshenker David, Rhythm and blues: Animal models of epilepsy and depression comorbidity, Biochemical Pharmacology, 85, 2, 2013. Crossref

  37. Favre Jean-Daniel, Allain Hervé, Aubin Henri-Jean, Frija-Orvoen Elisabeth, Gillet Claudine, Lejoyeux Michel, Payen Alain, Weber Michel, Garcia-Acosta Stéphanie, Kermadi Imane, Dib Michel, Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome, Human Psychopharmacology: Clinical and Experimental, 20, 7, 2005. Crossref

  38. Richerson George B., Buchanan Gordon F., The serotonin axis: Shared mechanisms in seizures, depression, and SUDEP, Epilepsia, 52, 2011. Crossref

  39. Borowicz Kinga K., Zarczuk Radosław, Latalski Michał, Borowicz Kornel M., Reboxetine and its influence on the action of classical antiepileptic drugs in the mouse maximal electroshock model, Pharmacological Reports, 66, 3, 2014. Crossref

  40. Troester Matthew, Naritoku Dean, Vagus Nerve Stimulation, in Epilepsy, 2010. Crossref

  41. Lagopoulos Jim, Malhi Gin S, Ivanovski Belinda, Cahill Catherine M, Morris John GL, A matter of motion or an emotional matter? Management of depression in Parkinson’s disease, Expert Review of Neurotherapeutics, 5, 6, 2005. Crossref

  42. Bureau Y., Handa M., Zhu Y., Laliberte F., Moore C.S., Liu S., Huang Z., MacDonald D., Xu D.G., Robertson G.S., Neuroanatomical and pharmacological assessment of Fos expression induced in the rat brain by the phosphodiesterase-4 inhibitor 6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline, Neuropharmacology, 51, 5, 2006. Crossref

  43. Hamid Hamada, Kanner Andres M., Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?, Epilepsy & Behavior, 26, 3, 2013. Crossref

  44. Borowicz Kinga K., Furmanek-Karwowska Kamila, Morawska Marta, Luszczki Jarogniew J., Czuczwar Stanislaw J., Effect of acute and chronic treatment with milnacipran potentiates the anticonvulsant activity of conventional antiepileptic drugs in the maximal electroshock-induced seizures in mice, Psychopharmacology, 207, 4, 2010. Crossref

  45. Mashour George A., Walker Erin E., Martuza Robert L., Psychosurgery: past, present, and future, Brain Research Reviews, 48, 3, 2005. Crossref

  46. Pahwa Priyanka, Goel Rajesh Kumar, Ameliorative effect of Asparagus racemosus root extract against pentylenetetrazol-induced kindling and associated depression and memory deficit, Epilepsy & Behavior, 57, 2016. Crossref

  47. Pineda Eduardo A, Hensler Julie G, Sankar Raman, Shin Don, Burke Teresa F, Mazarati Andréy M, Plasticity of Presynaptic and Postsynaptic Serotonin 1A Receptors in an Animal Model of Epilepsy-Associated Depression, Neuropsychopharmacology, 36, 6, 2011. Crossref

  48. Epps S Alisha, Tabb Kroshona D, Lin Sharon J, Kahn Alexa B, Javors Martin A, Boss-Williams Katherine A, Weiss Jay M, Weinshenker David, Seizure Susceptibility and Epileptogenesis in a Rat Model of Epilepsy and Depression Co-Morbidity, Neuropsychopharmacology, 37, 13, 2012. Crossref

  49. Johnson Michael R., Tan Nigel C.K., Kwan Patrick, Brodie Martin J., Newly diagnosed epilepsy and pharmacogenomics research: A step in the right direction?, Epilepsy & Behavior, 22, 1, 2011. Crossref

  50. Jamra Rami Abou, Schumacher Johannes, Golla Astrid, Richter Carola, Otte Andreas C.J., Schulze Thomas G., Ohlraun Stephanie, Maier Wolfgang, Rietschel Marcella, Cichon Sven, Propping Peter, Nöthen Markus M., Family-based association studies of α-adrenergic receptor genes in chromosomal regions with linkage to bipolar affective disorder, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 126B, 1, 2004. Crossref

  51. Mamalyga M. L., Mamalyga L. M., Monoamine metabolism in the brain after disruption of cerebral hemodynamics caused by acute blood loss, Neurochemical Journal, 11, 4, 2017. Crossref

  52. Fox Meredith A., Andrews Anne M., Wendland Jens R., Lesch Klaus-Peter, Holmes Andrew, Murphy Dennis L., A pharmacological analysis of mice with a targeted disruption of the serotonin transporter, Psychopharmacology, 195, 2, 2007. Crossref

  53. Mamalyga M. L., The metabolism of monoamines in the central nervous system during compensated and decompensated heart failure, Neurochemical Journal, 7, 1, 2013. Crossref

  54. Singh Tanveer, Goel Rajesh Kumar, Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression, Epilepsy & Behavior, 61, 2016. Crossref

  55. Kanner Andres M., Are Psychiatric Disorders a Risk for the Development of Neurological Disorders?, in Psychiatric Controversies in Epilepsy, 2008. Crossref

  56. García-Morales Irene, de la Peña Mayor Pilar, Kanner Andrés M, Psychiatric Comorbidities in Epilepsy: Identification and Treatment, The Neurologist, 14, 6, 2008. Crossref

  57. Cohen Hagit, Kaplan Zeev, Kotler Moshe, Mittelman Irena, Osher Yamima, Bersudsky Yuly, Impaired heart rate variability in euthymic bipolar patients, Bipolar Disorders, 5, 2, 2003. Crossref

  58. Jobe Phillip C., Shared Mechanisms of Antidepressant and Antiepileptic Treatments: Drugs and Devices, Clinical EEG and Neuroscience, 35, 1, 2004. Crossref

  59. Jobe Phillip C., Affective Disorder and Epilepsy Comorbidity: Implications for Development of Treatments, Preventions and Diagnostic Approaches, Clinical EEG and Neuroscience, 35, 1, 2004. Crossref

  60. Jobe Phillip C., Current and Future Therapeutic Opportunities in the Comorbidity between the Epilepsies and Affective Disorders, Clinical EEG and Neuroscience, 35, 1, 2004. Crossref

  61. JOBE PHILLIP C., BROWNING RONALD A., Mammalian Models of Genetic Epilepsy Characterized by Sensory-Evoked Seizures and Generalized Seizure Susceptibility, in Models of Seizures and Epilepsy, 2006. Crossref

  62. Ahern Todd H, Javors Martin A, Eagles Douglas A, Martillotti Jared, Mitchell Heather A, Liles Larry Cameron, Weinshenker David, The Effects of Chronic Norepinephrine Transporter Inactivation on Seizure Susceptibility in Mice, Neuropsychopharmacology, 31, 4, 2006. Crossref

  63. Tchekalarova J., Shishmanova M., Atanasova D., Stefanova M., Alova L., Lazarov N., Georgieva K., Effect of endurance training on seizure susceptibility, behavioral changes and neuronal damage after kainate-induced status epilepticus in spontaneously hypertensive rats, Brain Research, 1625, 2015. Crossref

  64. Kanner Andres M., The Behavioral Aspects of Epilepsy: An Overview of Controversial Issues, Epilepsy & Behavior, 2, 1, 2001. Crossref

  65. Borowicz Kinga K., Gołyska Dorota, Luszczki Jarogniew J., Czuczwar Stanislaw J., Effect of acutely and chronically administered venlafaxine on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model, European Journal of Pharmacology, 670, 1, 2011. Crossref

  66. Deepmala , Slattery John, Kumar Nihit, Delhey Leanna, Berk Michael, Dean Olivia, Spielholz Charles, Frye Richard, Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review, Neuroscience & Biobehavioral Reviews, 55, 2015. Crossref

  67. Kanner Andres M., Psychopathology and Epilepsy: Is it the Chicken or the Egg?, Epilepsy Currents, 6, 5, 2006. Crossref

  68. Jones Jana E., Are Anxiety and Depression Two Sides of the Same Coin?, in Psychiatric Controversies in Epilepsy, 2008. Crossref

  69. Jobe Phillip C., Common pathogenic mechanisms between depression and epilepsy: an experimental perspective, Epilepsy & Behavior, 4, 2003. Crossref

  70. Svob Strac Dubravka, Pivac Nela, Smolders Ilse J., Fogel Wieslawa A., De Deurwaerdere Philippe, Di Giovanni Giuseppe, Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs, Frontiers in Neuroscience, 10, 2016. Crossref

  71. Rubaj Andrzej, Zgodziński Witold, Sieklucka-Dziuba Maria, The epileptogenic effect of seizures induced by hypoxia, Pharmacology Biochemistry and Behavior, 74, 2, 2003. Crossref

  72. Kanner Andres M., Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence, Epilepsy & Behavior, 61, 2016. Crossref

  73. Ketcha Wanda Germain Jean Magloire, Ngitedem Steve Guemnang, Njamen Dieudonné, Botanicals for mood disorders with a focus on epilepsy, Epilepsy & Behavior, 52, 2015. Crossref

  74. Jobe Phillip C., Dailey John W., Genetically Epilepsy-Prone Rats (GEPRs) in Drug Research, CNS Drug Reviews, 6, 3, 2006. Crossref

  75. Paterson Louise M., Kornum Birgitte R., Nutt David J., Pike Victor W., Knudsen Gitte M., 5-HT radioligands for human brain imaging with PET and SPECT, Medicinal Research Reviews, 33, 1, 2013. Crossref

  76. Kanner Andres M., Epilepsy and mood disorders, Epilepsia, 48, 2007. Crossref

  77. Kanner Andres M, Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment, Biological Psychiatry, 54, 3, 2003. Crossref

  78. Smolders Ilse, Michotte Yvette, Chapter 5.3 The use of microdialysis for the study of neurological disorders, in Handbook of Microdialysis - Methods, Applications and Perspectives, 16, 2006. Crossref

  79. E Kurt, M Emul, O Ozbulut, O Guler, F Erdur, H Sağlam, O Gecici, Is valproate promising in cardiac fatal arrhythmias? Comparison of P- and Q-wave dispersion in bipolar affective patients on valproate or lithium–valproate maintenance therapy with healthy controls, Journal of Psychopharmacology, 23, 3, 2009. Crossref

  80. Tchekalarova Jana, Pechlivanova Daniela, Atanasova Tsvetomira, Markova Petya, Lozanov Valentin, Stoynev Alexander, Diurnal variations in depression-like behavior of Wistar and spontaneously hypertensive rats in the kainate model of temporal lobe epilepsy, Epilepsy & Behavior, 20, 2, 2011. Crossref

  81. Kanner Andres M, Depression in epilepsy: a complex relation with unexpected consequences, Current Opinion in Neurology, 21, 2, 2008. Crossref

  82. Verrotti Alberto, Carrozzino Danilo, Milioni Maddalena, Minna Maria, Fulcheri Mario, Epilepsy and its main psychiatric comorbidities in adults and children, Journal of the Neurological Sciences, 343, 1-2, 2014. Crossref

  83. Arida Ricardo M., Cavalheiro Esper A., Scorza Fulvio A., From depressive symptoms to depression in people with epilepsy: Contribution of physical exercise to improve this picture, Epilepsy Research, 99, 1-2, 2012. Crossref

  84. Borowicz Kinga K., Gurdziel Elwira, Czuczwar Stanisław J., Trazodone reduces the anticonvulsant action of certain classical antiepileptics in the mouse maximal electroshock model, Pharmacological Reports, 64, 5, 2012. Crossref

  85. Jones Nigel C., O'Brien Terence J., Stress, epilepsy, and psychiatric comorbidity: How can animal models inform the clinic?, Epilepsy & Behavior, 26, 3, 2013. Crossref

  86. Barry John J., Ettinger Alan B., Friel Peggy, Gilliam Frank G., Harden Cynthia L., Hermann Bruce, Kanner Andres M., Caplan Rochelle, Plioplys Sigita, Salpekar Jay, Dunn David, Austin Joan, Jones Jana, Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders, Epilepsy & Behavior, 13, 2008. Crossref

  87. Millan Mark J., Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application, Pharmacology & Therapeutics, 110, 2, 2006. Crossref

  88. Singh Damanpreet, Mishra Awanish, Goel Rajesh Kumar, Effect of saponin fraction from Ficus religiosa on memory deficit, and behavioral and biochemical impairments in pentylenetetrazol kindled mice, Epilepsy & Behavior, 27, 1, 2013. Crossref

  89. Lippert Trenton, Gelineau Lindsey, Napoli Eleonora, Borlongan Cesar V., Harnessing neural stem cells for treating psychiatric symptoms associated with fetal alcohol spectrum disorder and epilepsy, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 80, 2018. Crossref

  90. Giorgi Filippo S., Pizzanelli Chiara, Biagioni Francesca, Murri Luigi, Fornai Francesco, The role of norepinephrine in epilepsy: from the bench to the bedside, Neuroscience & Biobehavioral Reviews, 28, 5, 2004. Crossref

  91. Portelli Jeanelle, Aourz Najat, De Bundel Dimitri, Meurs Alfred, Smolders Ilse, Michotte Yvette, Clinckers Ralph, Intrastrain differences in seizure susceptibility, pharmacological response and basal neurochemistry of Wistar rats, Epilepsy Research, 87, 2-3, 2009. Crossref

  92. Borowicz Kinga K., Banach Monika, Piskorska Barbara, Czuczwar Stanisław J., Effect of acute and chronic tianeptine on the action of classical antiepileptics in the mouse maximal electroshock model, Pharmacological Reports, 65, 2, 2013. Crossref

  93. Smolders Ilse, Clinckers Ralph, Meurs Alfred, De Bundel Dimitri, Portelli Jeanelle, Ebinger Guy, Michotte Yvette, Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant–anticonvulsant action, Neuropharmacology, 54, 6, 2008. Crossref

  94. Barry John J., Jones Jana E., What is effective treatment of depression in people with epilepsy?, Epilepsy & Behavior, 6, 4, 2005. Crossref

  95. Alsaadi Taoufik, Zamel Khalid, Sameer Ahmed, Fathalla Waseem, Koudier Iyad, Depressive disorders in patients with epilepsy: Why should neurologists care?, Health, 05, 06, 2013. Crossref

  96. Bagdy Gyorgy, Kecskemeti Valeria, Riba Pal, Jakus Rita, Serotonin and epilepsy, Journal of Neurochemistry, 100, 4, 2007. Crossref

  97. Moyanova Slavianka, De Fusco Antonio, Santolini Ines, Celli Roberta, Bucci Domenico, Mastroiacovo Federica, Battaglia Giuseppe, Nicoletti Ferdinando, Tchekalarova Jane, Abnormal Hippocampal Melatoninergic System: A Potential Link between Absence Epilepsy and Depression-Like Behavior in WAG/Rij Rats?, International Journal of Molecular Sciences, 19, 7, 2018. Crossref

  98. Aguilar Brittany L., Malkova Ludise, N'Gouemo Prosper, Forcelli Patrick A., Genetically Epilepsy-Prone Rats Display Anxiety-Like Behaviors and Neuropsychiatric Comorbidities of Epilepsy, Frontiers in Neurology, 9, 2018. Crossref

  99. McLean M.J., Engström S., Holcomb R.R., Sanchez D., A static magnetic field modulates severity of audiogenic seizures and anticonvulsant effects of phenytoin in DBA/2 mice, Epilepsy Research, 55, 1-2, 2003. Crossref

  100. Kim Duk-Soo, Kim Ji-Eun, Kwak Sung-Eun, Kim Dae-Won, Choi Soo-Young, Kwon Oh-Shin, Kang Tae-Chon, Seizure activity selectively reduces 5-HT1A receptor immunoreactivity in CA1 interneurons in the hippocampus of seizure-prone gerbils, Brain Research, 1154, 2007. Crossref

  101. Kanner Andres M., Depression and Epilepsy: A Review of Multiple Facets of Their Close Relation, Neurologic Clinics, 27, 4, 2009. Crossref

  102. Manna Ida, Labate Angelo, Gambardella Antonio, Forabosco Paola, La Russa Antonella, Le Piane Emilio, Aguglia Umberto, Quattrone Aldo, Serotonin transporter gene (5-Htt): Association analysis with temporal lobe epilepsy, Neuroscience Letters, 421, 1, 2007. Crossref

  103. Malhi Gin S, Loo Colleen, Cahill Catherine M, Lagopoulos Jim, Mitchell Philip, Sachdev Perminder, "Getting physical": the management of neuropsychiatric disorders using novel physical treatments, Neuropsychiatric Disease and Treatment, 2, 2, 2006. Crossref

  104. Browning R.A., Jobe P.C., NEUROTRANSMITTER FUNCTION | Role of Noradrenergic System in Seizure Regulation, in Encyclopedia of Basic Epilepsy Research, 2009. Crossref

  105. Lévêque Marc, Les interventions de psychochirurgie, in Psychochirurgie, 2013. Crossref

  106. Midzyanovskaya I.S., Kuznetsova G.D., van Luijtelaar E.L.J.M., van Rijn C.M, Tuomisto L., MacDonald E., The brain 5HTergic response to an acute sound stress in rats with generalized (absence and audiogenic) epilepsy, Brain Research Bulletin, 69, 6, 2006. Crossref

  107. Weinshenker D., Tabb K.D., Szot P., PSYCHIATRIC SYMPTOMS | Norephinephrine: A Molecular Link Between Depression and Epilepsy?, in Encyclopedia of Basic Epilepsy Research, 2009. Crossref

  108. Tabb Kroshona, Boss-Williams Katherine A., Weiss Jay M., Weinshenker David, Rats bred for susceptibility to depression-like phenotypes have higher kainic acid-induced seizure mortality than their depression-resistant counterparts, Epilepsy Research, 74, 2-3, 2007. Crossref

  109. Kanner Andres M., Ictal Panic and Interictal Panic Attacks: Diagnostic and Therapeutic Principles, Neurologic Clinics, 29, 1, 2011. Crossref

  110. Brooks-Kayal Amy R., Bath Kevin G., Berg Anne T., Galanopoulou Aristea S., Holmes Gregory L., Jensen Frances E., Kanner Andres M., O'Brien Terence J., Whittemore Vicky H., Winawer Melodie R., Patel Manisha, Scharfman Helen E., Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy, Epilepsia, 54, 2013. Crossref

  111. Bob Petr, Consciousness and Functional Connectivity, in Brain, Mind and Consciousness, 2012. Crossref

  112. Kanner Andres M., Palac Susan, Neuropsychiatric complications of epilepsy, Current Neurology and Neuroscience Reports, 2, 4, 2002. Crossref

  113. Hamed Sherifa Ahmad, Psychiatric symptomatologies and disorders related to epilepsy and antiepileptic medications, Expert Opinion on Drug Safety, 10, 6, 2011. Crossref

  114. Groves Duncan A., Bowman Eric M., Brown Verity J., Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat, Neuroscience Letters, 379, 3, 2005. Crossref

  115. Harden Cynthia L., Sexual dysfunction in women with epilepsy, Seizure, 17, 2, 2008. Crossref

  116. Kaminski Rafal M., Shippenberg Toni S., Witkin Jeffrey M., Rocha Beatriz A., Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures, Neuroscience Letters, 382, 1-2, 2005. Crossref

  117. Lévêque Marc, Psychosurgical Procedures, in Psychosurgery, 2014. Crossref

  118. Marcangelo Michael J., Ovsiew Fred, Psychiatric Aspects of Epilepsy, Psychiatric Clinics of North America, 30, 4, 2007. Crossref

  119. Shim Stacey, El Mansari Mostafa, Blier Pierre, Modulation of the Antidepressant-Like Effects of Sustained Administration of Carisbamate and Lamotrigine on Monoaminergic Systems: Electrophysiological Studies in the Rat Brain, Journal of Pharmacology and Experimental Therapeutics, 347, 2, 2013. Crossref

  120. Vermoesen Katia, Serruys Ann-Sophie K., Loyens Ellen, Afrikanova Tatiana, Massie Ann, Schallier Anneleen, Michotte Yvette, Crawford Alexander D., Esguerra Camila V., de Witte Peter A.M., Smolders Ilse, Clinckers Ralph, Assessment of the convulsant liability of antidepressants using zebrafish and mouse seizure models, Epilepsy & Behavior, 22, 3, 2011. Crossref

  121. Miller J Mitchell, Kustra Robert P, Vuong Alain, Hammer Anne E, Messenheimer John A, Depressive Symptoms in Epilepsy, Drugs, 68, 11, 2008. Crossref

  122. Roth Gerhard, Dicke Ursula, Funktionelle Neuroanatomie des limbischen Systems, in Neurobiologie psychischer Störungen, 2006. Crossref

  123. Petrucci Alexandra N., Joyal Katelyn G., Purnell Benton S., Buchanan Gordon F., Serotonin and sudden unexpected death in epilepsy, Experimental Neurology, 325, 2020. Crossref

  124. Mazarati A., Siddarth P., Baldwin R. A., Shin D., Caplan R., Sankar R., Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine, Brain, 131, 8, 2008. Crossref

  125. Hrvoje Hecimovic, Jasminka Stefulj, Lipa Cicin-Sain, Vida Demarin, Branimir Jernej, Association of serotonin transporter promoter (5-HTTLPR) and intron 2 (VNTR-2) polymorphisms with treatment response in temporal lobe epilepsy, Epilepsy Research, 91, 1, 2010. Crossref

  126. Givon Lior, Porter Steven, Padmanabhan Bharanidharan, Goren Jessica, Cohen Pieter A., Levetiracetam, Seizures, and Suicidality, Harvard Review of Psychiatry, 19, 1, 2011. Crossref

  127. Borowicz-Reutt Kinga K., Banach Monika, Acute and chronic treatment with moclobemide, a reversible MAO-inhibitor, potentiates the antielectroshock activity of conventional antiepileptic drugs in mice, Pharmacology Biochemistry and Behavior, 201, 2021. Crossref

  128. Lu Elaine, Pyatka Nataliya, Burant Christopher J, Sajatovic Martha, Systematic Literature Review of Psychiatric Comorbidities in Adults with Epilepsy, Journal of Clinical Neurology, 17, 2, 2021. Crossref

  129. Fregni Felipe, Schachter Steven C., Pascual-Leone Alvaro, Transcranial magnetic stimulation treatment for epilepsy: Can it also improve depression and vice versa?, Epilepsy & Behavior, 7, 2, 2005. Crossref

  130. Kumari Neelam, Kaul Ankur, Varshney Raunak, Singh Vinay Kumar, Srivastava Krishna, Bhagat Sunita, Mishra Anil Kumar, Tiwari Anjani Kumar, Synthesis and evaluation of technetium-99m labelled 1-(2-methoxyphenyl)piperazine derivative for single photon emission computed tomography imaging for targeting 5-HT1A, Bioorganic Chemistry, 111, 2021. Crossref

  131. Ettinger Alan B., Reed Michael L., Goldberg Joseph F., Hirschfeld Robert M.A., Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders, Neurology, 65, 4, 2005. Crossref

  132. Rangaswamy Sandhya, Saklani Meenakshi, Kumar Rajnish, Mathur Rashi, Kaul Ankur, Tiwari Anjani K., Kaur‐Ghuman Sandeep, Mishra Anil K., Varshney Raunak, A Homobivalent SPECT Radioligand ‐ Serinol Appended Methoxyphenyl Piperazine Derivative for Serotonin Receptor Imaging**, ChemistrySelect, 6, 23, 2021. Crossref

  133. Godoy-Reyes Tania M., Costero Ana M., Gaviña Pablo, Martínez-Máñez Ramón, Sancenón Félix, A Colorimetric Probe for the Selective Detection of Norepinephrine Based on a Double Molecular Recognition with Functionalized Gold Nanoparticles, ACS Applied Nano Materials, 2, 3, 2019. Crossref

  134. Sadanandan Nadia, Saft Madeline, Gonzales-Portillo Bella, Borlongan Cesar V., Multipronged Attack of Stem Cell Therapy in Treating the Neurological and Neuropsychiatric Symptoms of Epilepsy, Frontiers in Pharmacology, 12, 2021. Crossref

  135. Bob Petr, Dissociation and Neurobiological Consequences of Traumatic Stress, Activitas Nervosa Superior, 50, 1-2, 2008. Crossref

  136. Bob Petr, Dissociation, Epileptiform Discharges and Chaos in the Brain: Toward a Neuroscientific Theory of Dissociation, Activitas Nervosa Superior, 54, 3-4, 2012. Crossref

  137. Thapliyal Surabhi, Singh Tanveer, Handu Shailendra, Bisht Manisha, Kumari Puja, Arya Priyanka, Srivastava Pallavi, Gandham Ravi, A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders, Neurochemical Research, 46, 5, 2021. Crossref

  138. Grunze Heinz C. R., The effectiveness of anticonvulsants in psychiatric disorders, Dialogues in Clinical Neuroscience, 10, 1, 2008. Crossref

  139. Hamed S, Mohamed K, El-taher A, Hamed E, Omar H, The sexual and reproductive health in men with generalized epilepsy: a multidisciplinary evaluation, International Journal of Impotence Research, 18, 3, 2006. Crossref

  140. Mantovani Antonio, Lisanby Sarah H., Brain stimulation in the treatment of anxiety disorders, in Anxiety Disorders, 2010. Crossref

  141. Treatment of anxiety: current status and controversial issues, in Anxiety Disorders, 2010. Crossref

  142. Bragatti José Augusto, Torres Carolina Machado, Assmann Juliana Bohn, Fontana Vivian, Rigotti Clarice Pereira, Hidalgo Maria Paz Loayza, Chaves Márcia Lorena Fagundes, Bianchin Marino Muxfeldt, Left-sided EEG focus and positive psychiatric family history are independent risk factors for affective disorders in temporal lobe epilepsy, Epilepsy Research, 87, 2-3, 2009. Crossref

  143. Mantovani Antonio, Stanford Arielle D., Bulow Peter, Lisanby Sarah H., Section II – Focal brain stimulation approaches to psychiatric treatment, in Cambridge Textbook of Effective Treatments in Psychiatry, 2008. Crossref

  144. Choi Hee-Soo, Park Joon Ha, Ahn Ji Hyeon, Hong Seongkweon, Cho Jun Hwi, Won Moo-Ho, Lee Choong-Hyun, The anti-inflammatory activity of duloxetine, a serotonin/norepinephrine reuptake inhibitor, prevents kainic acid-induced hippocampal neuronal death in mice, Journal of the Neurological Sciences, 358, 1-2, 2015. Crossref

  145. Yoshitake Takashi, Fujino Kaoru, Kehr Jan, Ishida Junichi, Nohta Hitoshi, Yamaguchi Masatoshi, Simultaneous determination of norepinephrine, serotonin, and 5-hydroxyindole-3-acetic acid in microdialysis samples from rat brain by microbore column liquid chromatography with fluorescence detection following derivatization with benzylamine, Analytical Biochemistry, 312, 2, 2003. Crossref

  146. Maguire Jamie, Mechanisms of Psychiatric Comorbidities in Epilepsy, in Psychiatric and Behavioral Aspects of Epilepsy, 55, 2020. Crossref

  147. Heller A Chris, Amar Arun P., Liu Charles Y., Apuzzo Michael L.J., Surgery of the Mind and Mood: A Mosaic of Issues in Time and Evolution, Neurosurgery, 59, 4, 2006. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain